291 related articles for article (PubMed ID: 4049307)
1. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
[TBL] [Abstract][Full Text] [Related]
2. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III Alger: a new homozygous AT III variant.
Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
6. Homozygous variant of antithrombin III: AT III Fontainebleau.
Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
[TBL] [Abstract][Full Text] [Related]
7. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
Tripodi A; Krachmalnicoff A; Mannucci PM
Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin III deficiency.
Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
[TBL] [Abstract][Full Text] [Related]
10. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease.
Girolami A; Pengo V; Cappellato G; Vianello C; Procidano M; Cartei C
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):98-111. PubMed ID: 6192061
[TBL] [Abstract][Full Text] [Related]
12. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
Sas G; Pepper DS; Cash JD
Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
[TBL] [Abstract][Full Text] [Related]
13. A tentative classification of AT III congenital abnormalities.
Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):661-9. PubMed ID: 2448207
[TBL] [Abstract][Full Text] [Related]
14. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
[TBL] [Abstract][Full Text] [Related]
15. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
Ambruso DR; Jacobson LJ; Hathaway WE
Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
[TBL] [Abstract][Full Text] [Related]
16. Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency.
Wolf M; Boyer-Neumann C; Molho-Sabatier P; Neumann C; Meyer D; Larrieu MJ
Thromb Haemost; 1990 Apr; 63(2):215-9. PubMed ID: 2363123
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
18. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and functional study of antithrombin III in newborn infants.
McDonald MM; Hathaway WE; Reeve EB; Leonard BD
Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville.
Aiach M; Roncato M; Chadeuf G; Dezellus P; Capron L; Fiessinger JN
Thromb Haemost; 1988 Aug; 60(1):94-6. PubMed ID: 3187951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
